FDA Inspections: How to Respond to a Request for an Affidavit By Alan P. Schwartz, Senior Partner, mdi Consultants Dealing with the FDA during an inspection could cause real emotional stress to say the least. Should you respect the request of FDA investigator if you are not sure what the consequences would be at a
FDA Encourages the Development of Generic Drugs As They Publish Product-Specific Guidances FDA published a new batch of product-specific guidances (PSGs). PSGs provide recommendations for developing generic drugs and generating the evidence needed to support abbreviated new drug application (ANDA) approval, helping to streamline generic product development and ANDA assessment. FDA publishes PSGs to help
FDA Update Just Announced… NEW FEES FY2023 User Fee Rates for the Voluntary Qualified Importer Program (VQIP) and the Accredited Third-Party Certification Program (TPP) The U.S. Food and Drug Administration (FDA) is announcing the fiscal year (FY) 2023 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP), and accreditation
FDA update RE: FDA Announces the Availability of a Proposed Rule: Revising the National Drug Code Format and Drug On July 22, 2022, FDA announced the availability of a proposed rule to adopt a single, uniform 12-digit format (a universal 6-4-2 format) for FDA-assigned NDCs. In addition, the FDA proposes to revise the label requirements
FDA Update PATIENT LABELING for HUMAN Rx and Biological Products Patients and Caregivers Alike Can Finally Rely on Clear Usage Instructions for Prescription and Biological Drugs as the FDA Issues Final Guidance on Instructions for Use Documents The U.S. Food and Drug Administration has issued a final guidance, “Instructions for Use – Patient Labeling for
FDA Update “Put Down the Wand” FDA Warns Against the Use of Certain Ultraviolet (UV) Wands That Give Off Unsafe Levels of Radiation Periodically what seems like a good idea goes awry. During the pandemic everyone was looking to keep all surfaces including hands disinfected. One method of disinfecting surfaces was the use of a
FDA Update According to the FDA a Permanent Solution to the Baby Formula Supply Chain Shortage is On the Way A baby formula problem caused by the FDA is that same FDA that is now trying to fix it. As usual, our REACTIVE government came up short in anticipating a problem and did not offer
FDA Update FDA Request for Advisory Committee Nominations: Consumer Organizations and Individuals The Food and Drug Administration seeks input from consumers on medical and scientific issues. A key method of ensuring that FDA obtains the points of view of consumers is by including Consumer Representatives on Agency advisory committees. The FDA, relies on their many
Further Protection Against Counterfeit, Stolen, Contaminated, or Otherwise Harmful Drugs is On the Way FDA is announcing the availability of two guidances to help trading partners comply with the Drug Supply Chain Security Act (DSCSA). These documents are critical steps toward implementing the DSCSA enhanced drug distribution security requirements that will go into effect on
CMG, a Canadian based medical supply manufacturer, supply chain management services provider, and fully integrated services provider, supplying certification and consulting services to global healthcare enterprises. CMG is proud to partner with mdi Consultants for global regulatory services for FDA, Health Canada, and other jurisdictions; and, Kinectrics.com for ASTM product certifications CGM Corporate office is headquartered
mdi Consultants